View Cart (0 items)


Omnicare to pay $124 million to settle fraud allegations

June 30, 2014
Cincinnati-based Omnicare Inc. is to pay more than $124 million in a settlement with the U.S. Department of Justice for allegedly offering financial incentives to healthcare facilities.
Read More

US regulator to tighten scrutiny on potential drug delay deals

June 24, 2014
The U.S. Federal Trade Commission has announced plans to increase probes into pharmaceutical deals that potentially harm competition by delaying the launch of generic drugs on the market.
Read More

Merck to take over hepatitis C drug maker

June 16, 2014
American pharmaceutical giant Merck & Co. is planning to buy Idenix Pharmaceuticals Inc., a Massachusetts-based company specializing in developing treatment for hepatitis C.
Read More

Teva gets approval for generic version of pain reliever Celebrex

June 11, 2014
The U.S. Food and Drug Administration (FDA) has approved the first generic versions of pain relieving drug product Celebrex (celecoxib).
Read More

Hikma Pharmaceuticals to take over US generic injectables manufacturer

June 5, 2014
London-based multinational company Hikma Pharmaceuticals PLC has reached an asset acquisition agreement with Ben Venue Laboratories for the purchase of its U.S. generic injectables division, Bedford Laboratories, for $300 million.
Read More

US pharma major Abbott to pay $2.9 billion for Chile's CFR

June 3, 2014
U.S. pharmaceuticals and healthcare products major Abbott Laboratories has agreed to acquire Chile-based pharmaceutical firm CFR Pharmaceuticals SA in a deal worth $2.9 billion.
Read More

Sun Pharma's response to FDA import ban seen as 'inadequate'

May 27, 2014
According to the U.S. Food and Drug Administration, Sun Pharma has failed to take sufficient measures to correct the violations that led to the enforcement action.
Read More

Teva recalls 39,000 bottles of drug products due to manufacturing standards violations

May 27, 2014
The recalled production includes 2,532 bottles of anti-diabetes drug glyburide, which are being pulled off the U.S. market due to deviations from Current Good Manufacturing Practice.
Read More

EU, US health officials team up to fight antimicrobial resistance

May 19, 2014
Health officials from both sides of the Atlantic have been working together to tackle antimicrobial resistance under their joint Transatlantic Taskforce on Antimicrobial Resistance.
Read More

Bayer to take over Merck's consumer care business in $14.2 billion deal

May 13, 2014
German pharmaceutical giant Bayer is acquiring the over-the-counter medicines business of U.S. rival Merck & Co., Inc.
Read More